Clinical significance of serum cytokines IL-1β, sIL-2R, IL-6, TNF-α, and IFN-ν in acute coronary syndrome

Chinese Medical Sciences Journal

Volumn 19, Issue 2, 2004, Pages 120-124

  Wang, Yan Ni ^a   Che, Shao Min ^a   Ma, Ai Qun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Cytokine; Inflammation

Indexed keywords

CREATINE KINASE MB; CYTOKINE; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX; UNSTABLE ANGINA PECTORIS; VENOUS BLOOD;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEPTORS, INTERLEUKIN-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3142619229     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. the Paul Dudley White Lecture 1995. Circulation 1996;94:2013-20.
2. Virmani R, Burke AP, Farb A, et al. Pathology of the unstable plaque. Prog Cardiovasc Dis 2002;44:349-56.
3. Gutstein DE, Fuster V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res 1999;41:323-33.
4. Meuwissen M, van der W, Allard C, et al. Association betweencomplex coronary artery stenosis and unstable angina and the extent of plaque inflammation. Am J Med 2003;114:521-7.
5. Newby AC, Zaltsman AB. Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell prolixferation, migration and matrix formation. Cardiovasc Res 1999;41:345-60.
6. Weyand CM, Goronzy JJ, Liuzzo G, et al. T-cell immunity in acute coronary syndromes. Mayo Clin Proc 2001;76:1011-20.
7. Liuzzo G, Goronzy JJ, Yang HY, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000;101:2883-8.
8. Hojo Y, Ikeda U, Takahashi M, et al. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002;161:403-8.
9. Kelley JL, Chi DS, Abou-Auda W, et al. The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol Med Today 2000;6:304-8.
10. Galen S, Wagner CJ. Evaluation of a QRS Scoring System for Estimating Myocardial Infarct Size. Circulation 1982;62:342-7.
11. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003;169:203-14.
12. Frederick VL. Makers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2002;293:31-52.
13. Parker III C, Vita JA, Freedman JE. Soluble adhesion molecules and unstable coronary artery disease. Atherosclerosis 2001;156:417-24.
14. Doo YC, Han SJ, Lee JH, et al. Asociations among oxidized low-density lipoprotein antibody, C-reative protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris. Am J Cardiol 2004;93:554-8
15. Nicola F, Carlo G, Euro P, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999;145:51-60.
16. Gerszten RE, Mach F, Sauty A, et al. Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 2000;136:87-92.
17. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001, 88(8, Suppl 1):10-15.
18. Crook MF, Newby AC, Southgate KM. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis 2000;150:33-41.
19. Kim HH, Kim K. Enhancement of TNF-α-mediated cell death in vascular smooth muscle cells through cytochrome c-independent pathway by the proteasome inhibitor. Mol Med Today 2003;535: 190-4.
20. Gidron Y, Gilutz H, Berger R, et al. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res 2002;56:15-21.
21. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.